Astera Labs (NASDAQ:ALAB) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Astera Labs (NASDAQ:ALAB) posted its quarterly earnings data on Tuesday. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13, FiscalAI reports. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. During the same period in the previous year, the firm posted $0.49 earnings per share. The business’s revenue for the quarter was up 153.6% compared to the same quarter last year.

Here are the key takeaways from Astera Labs’ conference call:

• Record Q3 performance: Revenue reached $584.9 million, up 49% sequentially and 154% year over year, while non-GAAP operating margin expanded to 44.7% and EPS rose 65% sequentially to $1.32.
• Strong near-term outlook: Astera guided for Q4 revenue of $730 million to $750 million, representing 27% sequential growth at the midpoint, driven by continued Scorpio X-Series and P-Series expansion and growing Aries and Taurus demand.
• Scorpio momentum broadened: Scorpio became the company’s largest product family, with annualized revenue exceeding $1 billion; management cited new customer ramps, additional platforms, and continued growth opportunities into 2027.
• New growth vectors are progressing: Optical connectivity, Leo memory controllers, custom silicon, and Orion rack-scale platforms are expanding Astera’s addressable market, although most are expected to contribute meaningful revenue beginning in late 2027 or 2028.
• Investment and execution remain key risks: Q4 operating expenses are expected to rise to $194 million–$200 million as the company funds new initiatives, while several opportunities—including UALink, optical products, custom solutions, and Orion—remain dependent on customer qualification and future platform ramps.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $233.62 on Wednesday. The company has a 50-day simple moving average of $306.13 and a 200-day simple moving average of $255.53. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The stock has a market capitalization of $40.53 billion, a price-to-earnings ratio of 115.65 and a beta of 3.85.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record Q3 revenue of $584.9 million, up 49% quarter over quarter and 154% year over year. Adjusted earnings of $1.32 per share beat the $1.19 consensus estimate, as did revenue versus expectations of $550.78 million. Astera Labs Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Growth was led by the Scorpio fabric-switch family, now Astera Labs’ largest product line, with volume production of the Scorpio X-Series 320-lane switch. The company also expanded products for memory, optical and copper connectivity, and rack-scale AI systems—supporting its opportunity in AI infrastructure. Q3 2026 Earnings Call Highlights
• Positive Sentiment: Reports said the company’s forward guidance also topped estimates, adding to the earnings beat and potentially reinforcing expectations for continued demand. Astera Labs Q3 Results and Guidance
• Negative Sentiment: The results arrive after a sharp retreat: a recent report said ALAB had fallen about 54% from its year-to-date high and broken below key support. That weakness may keep volatility elevated and leave investors focused on whether earnings growth can restore confidence. Astera Labs Stock and Key Support

Analysts Set New Price Targets

A number of research firms have recently commented on ALAB. Needham & Company LLC boosted their price objective on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. TD Cowen dropped their price objective on shares of Astera Labs from $375.00 to $300.00 and set a “hold” rating for the company in a report on Monday, October 19th. Morgan Stanley increased their price target on Astera Labs from $240.00 to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Eleven investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $340.79.

Insider Buying and Selling

In other news, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares in the company, valued at $909,842.64. The trade was a 73.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 in the last ninety days. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.